Jimenez, Cyril James .

HRN: 08-02-10  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/25/2024
CEFUROXIME 1.5GM (VIAL)
10/25/2024
11/01/2024
IV
1.5g
Q8h
Laceration
Waiting Final Action 
10/25/2024
CEFUROXIME 1.5GM (VIAL)
10/25/2024
11/01/2024
IV
1.5g
Q8h
Laceration
Waiting Final Action 
10/28/2024
OXACILLIN 500MG (VIAL)
10/28/2024
11/04/2024
IV
500mg
Q6
Tbi
Waiting Final Action 
10/28/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
10/28/2024
11/04/2024
IV
500mg
Q8
Tbi
Waiting Final Action 
10/28/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
10/28/2024
11/04/2024
IV
300mg
Q6
Tbi
Waiting Final Action 
10/29/2024
CLOXACILLIN 500MG (CAP)
10/29/2024
11/05/2024
IV
500mg
Q6
TBI; Multiple STCs
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: